Clinical Trials
6 trialsNCT07120451 2025-08-13
Combination Therapy of Senaparib and Bevacizumab for First-line Maintenance Therapy in Newly Diagnosed Advanced Homologous Recombination Proficient Ovarian Cancer Based on Exosome Protein Marker
Fudan University
Phase 2 Not yet recruiting
NCT04065009 2024-01-11
IPLA-OVCA
Karolinska Institutet
Phase 3 Active not recruiting
NCT03161132 2023-01-27
ROLANDO
Grupo Español de Investigación en Cáncer de Ovario
Phase 2 Completed
NCT04360629 2022-06-01
Efficacy and Safety of Tranexamic Acid in Cytoreductive Surgery for Ovarian Cancer
Fudan University
Phase NA Completed
NCT03611179 2018-08-02
Upfront Treatment With Chemotherapy and Bevacizumab in Advanced Ovarian Cancer
Assiut University
Phase 2 Unknown
NCT01462149 2017-05-31
Efficacy Study of Neoadjuvant Chemotherapy to Treat Advanced Ovarian Cancer
Asan Medical Center
Phase 2 Completed